# General Cybernetics

Boston biotech working on gene editing in embryos to prevent genetic disease. Raised $15.3M. Still in stealth.

Researched with Autumn (https://www.autumn.ai) from public records. Updated 2026-11-16. 12 sources. All stealth startups: https://www.autumn.ai/resources/stealth-startups

General Cybernetics is a Boston biotech company developing gene editors for use in embryos, with the stated goal of preventing genetic disease. Its team has described a CRISPR editor with a built-in off-switch, and a hiring post describes "controllable gene editors with inducible safety switches". A Form D filed with the SEC on 2026-09-09 shows $15,306,982 sold to 36 investors, including SAFEs that converted into equity. Autumn found this company from that SEC Form D. Its website says the company is in stealth, and no news article about it or the round was found as of 2026-11-16.

The first public record is from July 3, 2023. No press found as of November 16, 2026. The record that gave it away is an SEC Form D dated September 9, 2026.

## Facts

- Legal name: General Cybernetics Corp
- Sector: Biotech, gene editing
- Based in: Boston, MA
- Website: https://generalcybernetics.org
- What the site says today: Coming soon. This company is currently in stealth.
- Raised: $15.3M (SEC Form D, total sold) [1](https://www.sec.gov/Archives/edgar/data/2154072/000215407226000001/primary_doc.xml)
- Signals: Incorporation filing, Domain registration, Founder departure, Website, Job posting, SEC Form D

## The paper trail

Certificate validity starts can precede CT logging; they do not always establish an exact first-public date.

- **Jul 3, 2023** · Domain registration: generalcybernetics.org registered. The current registration record for generalcybernetics.org was created on 2023-07-03. The record does not show who registered it. [1](https://rdap.org/domain/generalcybernetics.org)
- **2024** · Incorporation filing: Incorporated in Delaware. The Form D gives 2024 as the year of incorporation and Delaware as the jurisdiction. The exact date is not in the filing. [1](https://www.sec.gov/Archives/edgar/data/2154072/000215407226000001/primary_doc.xml)
- **2024** · Founder departure: Cofounder leaves Saronic. Aydin Gokce's public profile lists a software engineering role at Saronic Technologies ending in 2024. A Foresight Institute profile describes him as a cofounder at General Cybernetics who previously worked at Saronic. [1](https://www.linkedin.com/in/aydin-gokce) [2](https://foresight.org/people/aydin-gokce/)
- **Feb 27, 2025** · Website: First archived page under the company name. The Wayback Machine's first capture of the current site is a page titled "General Cybernetics" with no other text. [1](https://web.archive.org/web/20250227044844/https://generalcybernetics.org/)
- **Jan 5, 2026** · Public record: Presentation to a New Hampshire legislative caucus. Aydin Gokce and Genesis Lung presented "Safer Gene Editing Technologies in Reproductive Medicine" to the New Hampshire Emerging Technologies Caucus. The caucus notes describe a CRISPR editor with a built-in off-switch meant to avoid mosaicism in embryos. [1](https://www.emergingtechnh.org/events/694017122a90f7a559833c88)
- **Mar 18, 2026** · Website: Site says "Launching Q2 2026". An archived copy of the homepage shows a logo, the line "Launching Q2 2026" and a contact button. The page description reads "Next-Gen Reproductive Therapies." [1](https://web.archive.org/web/20260318093206/https://generalcybernetics.org/)
- **Mar 26, 2026** · Public record: CEO speaks on embryo editing at FII PRIORITY Miami. The FII Institute's recap of a biotech session quotes Aydin Gokce, identified as CEO of General Cybernetics, saying "The things you can cure now are genetic diseases" and describing embryo editing to correct pathogenic mutations. [1](https://fii-institute.org/press/this-article-draws-on-two-afternoon-sessions-at-fii-priority-miami-2026-fii-hotseat-biotech-as-freedom-and-how-to-define-champions-of-the-intelligence-age/)
- **Apr 29, 2026** · Job posting: Hiring post for two research roles. Genesis Lung posted that General Cybernetics is hiring a research associate and a research scientist, calling it "an early startup with several million in current funding". Applicants were told to write to an address at generalcybernetics.org. The post went up 133 days before the Form D. [1](https://www.linkedin.com/posts/genesis-lung-123ab993_general-cybernetics-is-hiring-we-are-an-activity-7455360974276177920-ZUOw)
- **Aug 26, 2026** · Funding: Date of first sale in the round. The Form D gives 2026-08-26 as the date of first sale. [1](https://www.sec.gov/Archives/edgar/data/2154072/000215407226000001/primary_doc.xml)
- **Sep 9, 2026** · SEC Form D: SEC Form D filed: $15.3M sold. The filing reports $15,306,982 offered and sold to 36 investors, in equity and "SAFEs converted into equity in this transaction". It names Aydin Gokce as executive officer and director, signing as Chief Executive Officer, and Viraj Chhajed as a director. [1](https://www.sec.gov/Archives/edgar/data/2154072/000215407226000001/primary_doc.xml)
- **Nov 16, 2026** · Website: Site says the company is in stealth. The homepage shows "Coming soon. This company is currently in stealth." above a password field. The Q2 2026 launch line is gone. [1](https://generalcybernetics.org)
- **Nov 16, 2026** · No press found as of November 16, 2026.

## The records themselves

- SEC Form D, Sep 9, 2026: Form D, Item 13: offering and sales amounts. Total amount sold: $15,306,982, the whole offering. That's the $15.3M in the article. [Full record at SEC EDGAR](https://www.sec.gov/Archives/edgar/data/2154072/000215407226000001/xslFormDX01/primary_doc.xml) (captured Nov 16, 2026, excerpt)
- SEC Form D, Sep 9, 2026: Form D, EDGAR filing date. EDGAR lists 2026-09-09 as the filing date for General Cybernetics Corp's Form D. [Full record at SEC EDGAR](https://www.sec.gov/Archives/edgar/data/2154072/000215407226000001/0002154072-26-000001-index.htm) (captured Nov 16, 2026, excerpt)

## The website, then and now

- Mar 18, 2026: Wayback Machine capture, 2026-03-18: a logo, "Launching Q2 2026" and a contact button. [archive](https://web.archive.org/web/20260318093206/https://generalcybernetics.org/)
- Nov 16, 2026: Live site on 2026-11-16: "Coming soon. This company is currently in stealth." and a password field. [archive](https://generalcybernetics.org)

In March 2026 the homepage said "Launching Q2 2026". In November 2026 it says the company is in stealth and asks for a password.

## Founders

- [Aydin Gokce](https://www.autumn.ai/resources/stealth-startups/people/aydin-gokce), Cofounder and CEO: Signed General Cybernetics' Form D as CEO; earlier a software engineer at Saronic and an 8VC engineering fellow.

## What we don't know

- Who the 36 investors are. The Form D names none.
- The exact incorporation date. The Form D gives only the year, 2024.
- Who registered generalcybernetics.org in 2023, before the stated year of incorporation.
- Whether the Q2 2026 launch on the March 2026 homepage happened in any form.
- How far the research has progressed. No paper, patent or regulatory filing was found as of 2026-11-16.

## Sources

1. https://rdap.org/domain/generalcybernetics.org
2. https://www.sec.gov/Archives/edgar/data/2154072/000215407226000001/primary_doc.xml
3. https://www.linkedin.com/in/aydin-gokce
4. https://foresight.org/people/aydin-gokce/
5. https://web.archive.org/web/20250227044844/https://generalcybernetics.org/
6. https://www.emergingtechnh.org/events/694017122a90f7a559833c88
7. https://web.archive.org/web/20260318093206/https://generalcybernetics.org/
8. https://fii-institute.org/press/this-article-draws-on-two-afternoon-sessions-at-fii-priority-miami-2026-fii-hotseat-biotech-as-freedom-and-how-to-define-champions-of-the-intelligence-age/
9. https://www.linkedin.com/posts/genesis-lung-123ab993_general-cybernetics-is-hiring-we-are-an-activity-7455360974276177920-ZUOw
10. https://generalcybernetics.org
11. https://www.sec.gov/Archives/edgar/data/2154072/000215407226000001/xslFormDX01/primary_doc.xml
12. https://www.sec.gov/Archives/edgar/data/2154072/000215407226000001/0002154072-26-000001-index.htm

## The Autumn prompt

> Profile these five companies that surfaced through SEC Form D filings, one row per company: General Cybernetics (embryo gene editing), Kunin Technologies (critical minerals from mining waste), Path Power (autonomous underground drilling robot for power lines), Autonymy (founded by ex-Anduril people) and Fluidstack (AI cloud). For each, give the legal name, what it does, sector, HQ, website and what the site says today, every founder and named officer, and a dated paper trail: incorporation, domain registration, each Form D (filing date, date of first sale, amount sold), patents, job posts, founder departures from prior employers, subdomains and the first press coverage with outlet and date. Include a source URL for each field.

Run your own: https://platform.autumn.ai/sign-up

Corrections and removal requests: founders@autumnai.com
